Blood Plasma Derivatives Market Size, Demand & Analysis 2028
[Research Report] The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028.
Plasma derivatives are obtained from explicit plasma proteins by the cycle of fractionation. Blood plasma derivatives contain a high amount of proteins, salts, minerals, hormones, vitamins, and protease inhibitors. Thus, they are commonly used to destroy viruses that trigger bleeding disorders, hepatitis B, hepatitis C, hemophilia A, immunodeficiency, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus.
The blood plasma derivatives market is segmented on the basis of type, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the world's leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Plasma Derivatives Market: Strategic Insights
Market Size Value in US$ 29.886.12 million in 2022 Market Size Value by US$ 51,119.24 million by 2028 Growth rate CAGR of 9.4% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Plasma Derivatives Market: Strategic Insights
| Market Size Value in | US$ 29.886.12 million in 2022 |
| Market Size Value by | US$ 51,119.24 million by 2028 |
| Growth rate | CAGR of 9.4% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights – Blood Plasma Derivatives Market
Increasing Usage of Immunoglobulin G in Multiple Treatments to Offer Opportunities for Blood Plasma Derivatives Market in Coming Years
Immunoglobulin G (IgG) therapies are highly used to treat primary immune deficiency caused by genetic defects. The demand for IgG has been increasing steadily for the last few years due to the increasing awareness of IgG therapy. Based on controlled trials done by Network Meta Analysis (NMA), IgG therapy has been approved for the treatment of guillain-barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and dermatomyositis. IgG therapies are also effective for treating myasthenia gravis exacerbations and stiff-person syndrome. In addition, it provides convincing efficacy in autoimmune disorders such as epilepsy, neuromyelitis, and autoimmune encephalitis.
- In 2022, Grifols entered an agreement with Canadian Blood Services. This agreement accelerate self-sufficiency in immunoglobulins for Canada. Under the agreement, Grifols will work with Canadian Blood Services to gradually increase the sourcing of plasma in Canada to reach volumes to 2.4 million grams of Ig medicines annually by 2026.
- In 2021, the Food and Drug Administration (FDA) approved Cutaquig for medical use. It is used as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients of 2 years and above. Cutaquig is a ready-to-use immune globulin solution for subcutaneous infusion. The product is available in 1g, 1.65g, 2g, 3.3g, 4g, or 8g single-use vials.
- In August 2020, Kedrion Biopharma (Italy) began improving a plasma-inferred treatment for treating COVID-19 patients. The treatment could be accessible to patients in three to a half years.
A large proportion of IgG is used in specialties outside of immunology, such as oncology, neurology, hematology, and rheumatology. Compared to all, neurology is the fastest-growing specialty in the global market. The Immunoglobulin G market growth is attributed to its approval for on-label use for chronic inflammatory demyelinating polyneuropathy (CIDP) followed by its off-label use in secondary immune deficiencies caused by lymphoma, myeloma, and leukemia and the certain immunosuppressive therapies esp. B-cell targeting therapies. Thus, the wide range of IgG usage in multiple treatments for on-label and off-label prescriptions will drive IgG demand across the world in the coming years.
End User Insights
Based on end user, the global blood plasma derivatives market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. The increasing number of hospital admissions and a rising prevalence of von Willebrand disease, immunodeficient disorders, and hemophilia are projected to drive market growth for the hospital segment during the forecast period. Moreover, emerging nations are witnessing huge demand for advanced hospital settings to cope with the increasing patient pool and rising public health concerns. Furthermore, various immunoglobulin replacement therapies are conducted in hospitals to observe the doses and adverse events related to the therapy and to monitor clinical outcomes of the product. Hospitals are primary centers for providing immunoglobulin replacement therapies, which are being developed using new technologies. Patients receiving immune globulin therapies in hospitals perceive the advantages of greater safety, closer monitoring, and support from health professionals and experts. Thus, benefits provided by hospitals, such as proper patient-centric care and availability of reimbursement facilities, are expected to fuel market growth for the segment during the forecast period.
Product launches and mergers and acquisitions are among the highly adopted strategies by the global blood plasma derivatives market players. A few of the recent key product developments are listed below:
- In April 2022, Grifols announced the acquisition completion of 100% of the share capital of Tiancheng (Germany) Pharmaceutical Holdings AG. Tiancheng (Germany) Pharmaceutical Holdings AG is a German company that holds 89.88% of the ordinary shares and 1.08% of the preferred shares of Biotest AG. Following the Public Takeover Offer (PTO) completion and the acquisition closing, Grifols controls 96.20% of the voting rights and holds 69.72% of the share capital of Biotest AG.
Blood Plasma Derivatives Market Report Scope
Blood Plasma Derivatives – Market Segmentation
Based on type, the blood plasma derivatives market is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The market for the immunoglobulin segment is further segmented into IgG, IgM, IgA, IgD, and IgE. By application, the blood plasma derivatives market is segmented into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The market, by end user, is segmented into hospitals, clinics, and others. Based on geography, the blood plasma derivatives market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles – Blood Plasma Derivatives Market
- Grifols, S.A.
- SK Plasma Co., Ltd.
- Fusion Healthcare
- Biotest AG
- Green Cross Corp
- Kedrion
- LFB S.A.
- Octapharma AG
- CSL Limited
- Takeda Pharmaceutical Company Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The blood plasma derivative market is analyzed in the basis of type, application, and end use. Based on type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held the largest share of the blood plasma derivative market size, and it is anticipated to register the highest CAGR.
The blood plasma derivative market majorly consists of the players such as Grifols, S.A., SK Plasma Co., Ltd., Fusion Healthcare, Biotest AG, Green Cross Corp, Kedrion, LFB S.A., Octapharma AG, CSL Limited, and Takeda Pharmaceutical Company Limited.
The factors that are driving the growth of market are increasing prevalence of blood disorders across the world followed by rising geriatric population. However, high cost of blood plasma therapy followed by complicated reimbursement policies are the major factor hampering the growth of the market.
Blood plasma is the liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains blood pressure and helps exchange important minerals such as sodium and potassium for maintaining the body's pH balance. Plasma derivatives are products manufactured from human plasma using plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Blood Plasma Derivatives Market – by Type
1.3.2 Global Blood Plasma Derivatives Market – by Application
1.3.3 Global Blood Plasma Derivatives Market – by End User
1.3.4 Global Blood Plasma Derivatives Market – by Geography
2. Blood Plasma Derivatives Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Blood Plasma Derivatives Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. Blood Plasma Derivatives Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. Blood Plasma Derivatives Market – Global Analysis
6.1 Global Blood Plasma Derivatives Market Revenue Forecast and Analysis
6.2 Global Blood Plasma Derivatives Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Top Market Players
6.4.1 CSL Behring
6.4.2 Grifols, S.A.
7. Global Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application
8.1 Overview
8.2 Global Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Geographical Analysis
10.1 North America Blood Plasma Derivatives Market
10.1.1 Overview
10.1.2 North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.4 North America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.5 North America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.1.3.1 US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.1.4 US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.5 US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.2.3.1 Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.2.5 Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.3.3.1 Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2 Europe Blood Plasma Derivatives Market
10.2.1 Overview
10.2.2 Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.3.1 Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.4 Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.5 Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6 Europe: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.3.1 Germany: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.6.1.5 Germany Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.3.1 France: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.2.6.2.4 France: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.2.6.2.5 France Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.2.6.3 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.1 Overview2
10.2.6.3.2 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.3 Italy: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.3.3.1 Italy: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.2.6.3.4 Italy: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.3.5 Italy Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
10.2.6.4 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.1 Overview5
10.2.6.4.2 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.3 Spain: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)5
10.2.6.4.3.1 Spain: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.2.6.4.4 Spain: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)6
10.2.6.4.5 Spain Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.2.6.5 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.1 Overview8
10.2.6.5.2 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.3 United Kingdom: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.2.6.5.3.1 United Kingdom: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.2.6.5.4 United Kingdom: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.2.6.5.5 United Kingdom Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.2.6.6 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.1 Overview1
10.2.6.6.2 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.3 Rest of Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.6.3.1 Rest of Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.2.6.6.4 Rest of Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.6.5 Rest of Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3 Asia Pacific Blood Plasma Derivatives Market4
10.3.1 Overview4
10.3.2 Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.3.3 Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)6
10.3.3.1 Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.3.4 Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)7
10.3.5 Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.3.6 Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)8
10.3.6.1 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.1 Overview8
10.3.6.1.2 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.3 Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)9
10.3.6.1.3.1 Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.3.6.1.4 Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.3.6.1.5 Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.3.6.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.1 Overview1
10.3.6.2.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.3 China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.3.6.2.3.1 China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.3.6.2.4 China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.3.6.2.5 China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3.6.3 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.1 Overview4
10.3.6.3.2 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.3 India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.3.6.3.3.1 India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)5
10.3.6.3.4 India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.3.6.3.5 India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)6
10.3.6.4 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.1 Overview7
10.3.6.4.2 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.3 Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.3.6.4.3.1 Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)8
10.3.6.4.4 Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.3.6.4.5 Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.3.6.5 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.1 Overview0
10.3.6.5.2 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.3 South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.3.6.5.3.1 South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.3.6.5.4 South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.3.6.5.5 South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.3.6.6 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.1 Overview3
10.3.6.6.2 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.3 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.3.6.6.3.1 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.3.6.6.4 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.3.6.6.5 Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4 Middle East & Africa Blood Plasma Derivatives Market6
10.4.1 Overview6
10.4.2 Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.4.3 Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.4.3.1 Middle East & Africa: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)8
10.4.4 Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.4.5 Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.4.5.1 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.1 Overview0
10.4.5.1.2 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.3 UAE: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.4.5.1.3.1 UAE: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.4.5.1.4 UAE: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.4.5.1.5 UAE Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.4.5.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.1 Overview3
10.4.5.2.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.3 Saudi Arabia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.4.5.2.3.1 Saudi Arabia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.4.5.2.4 Saudi Arabia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.4.5.2.5 Saudi Arabia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4.5.3 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.1 Overview6
10.4.5.3.2 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.3 South Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.4.5.3.3.1 South Africa: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.4.5.3.4 South Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.4.5.3.5 South Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.4.5.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.1 Overview9
10.4.5.4.2 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.3 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.4.5.4.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)0
10.4.5.4.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.4.5.4.5 Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5 South & Central America Blood Plasma Derivatives Market2
10.5.1 Overview2
10.5.2 South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.5.3 South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.5.3.1 South & Central America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.5.4 South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.5.5 South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.5.5.1 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.1 Overview6
10.5.5.1.2 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.3 Brazil: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.5.5.1.3.1 Brazil: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.5.5.1.4 Brazil: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.5.5.1.5 Brazil Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.5.5.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.1 Overview9
10.5.5.2.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.3 Argentina: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.5.5.2.3.1 Argentina: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.5.5.2.4 Argentina: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.5.5.2.5 Argentina Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5.5.3 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.1 Overview2
10.5.5.3.2 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.3 Rest of South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.5.5.3.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.5.5.3.4 Rest of South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.5.5.3.5 Rest of South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
11. Impact of COVID 19 Pandemic On Global Blood Plasma Derivatives Market5
11.1 North America: Impact Assessment of COVID-19 Pandemic5
11.2 Europe: Impact Assessment of COVID-19 Pandemic7
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic9
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic1
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic3
12. Industry Landscape5
12.1 Overview5
12.2 Growth Strategies in the Blood Plasma Derivatives Market5
12.3 Inorganic Growth Strategies5
12.3.1 Overview5
12.4 Organic Growth Strategies7
12.4.1 Overview7
13. Company Profiles8
13.1 Grifols SA8
13.1.1 Key Facts8
13.1.2 Business Description8
13.1.3 Products and Services8
13.1.4 Financial Overview9
13.1.5 SWOT Analysis0
13.1.6 Key Developments1
13.2 SK Plasma Co Ltd2
13.2.1 Key Facts2
13.2.2 Business Description2
13.2.3 Products and Services2
13.2.4 Financial Overview2
13.2.5 SWOT Analysis3
13.2.6 Key Developments3
13.3 Octapharma AG4
13.3.1 Key Facts4
13.3.2 Business Description4
13.3.3 Products and Services4
13.3.4 Financial Overview5
13.3.5 SWOT Analysis6
13.3.6 Key Developments6
13.4 Monobind Inc.7
13.4.1 Key Facts7
13.4.2 Business Description7
13.4.3 Products and Services7
13.4.4 Financial Overview7
13.4.5 SWOT Analysis8
13.4.6 Key Developments8
13.5 Intas Pharmaceuticals Ltd9
13.5.1 Key Facts9
13.5.2 Business Description9
13.5.3 Products and Services9
13.5.4 Financial Overview9
13.5.5 SWOT Analysis0
13.5.6 Key Developments0
13.6 Fusion Health Care Pvt Ltd1
13.6.1 Key Facts1
13.6.2 Business Description1
13.6.3 Products and Services1
13.6.4 Financial Overview1
13.6.5 SWOT Analysis2
13.6.6 Key Developments2
13.7 Takeda Pharmaceutical Co Ltd3
13.7.1 Key Facts3
13.7.2 Business Description3
13.7.3 Products and Services4
13.7.4 Financial Overview4
13.7.5 SWOT Analysis6
13.7.6 Key Developments6
13.8 CSL Behring LLC7
13.8.1 Key Facts7
13.8.2 Business Description7
13.8.3 Products and Services7
13.8.4 Financial Overview8
13.8.5 SWOT Analysis9
13.8.6 Key Developments9
13.9 LFB SA1
13.9.1 Key Facts1
13.9.2 Business Description1
13.9.3 Products and Services1
13.9.4 Financial Overview1
13.9.5 SWOT Analysis2
13.9.6 Key Developments2
13.10 Kedrion SpA3
13.10.1 Key Facts3
13.10.2 Business Description3
13.10.3 Products and Services3
13.10.4 Financial Overview4
13.10.5 SWOT Analysis5
13.10.6 Key Developments6
14. Appendix7
14.1 About The Insight Partners7
14.2 Glossary of Terms7
LIST OF TABLES
Table 1. North America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. France Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)0
Table 27. France Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 28. France Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)1
Table 29. Italy Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 30. Italy Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)3
Table 31. Italy Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 32. Italy Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 33. Spain Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)5
Table 34. Spain Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 35. Spain Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)6
Table 36. Spain Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 37. United Kingdom Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 38. United Kingdom Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 39. United Kingdom Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 40. United Kingdom Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 41. Rest of Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 42. Rest of Europe Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 43. Rest of Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 44. Rest of Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 45. Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)6
Table 46. Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 47. Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)7
Table 48. Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 49. Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)9
Table 50. Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 51. Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 52. Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 53. China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 54. China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 55. China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)2
Table 56. China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 57. India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)4
Table 58. India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)5
Table 59. India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 60. India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 61. Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)7
Table 62. Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 63. Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)8
Table 64. Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 65. South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)0
Table 66. South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 67. South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 68. South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 69. Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)3
Table 70. Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)4
Table 71. Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)4
Table 72. Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)5
Table 73. Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 74. Middle East & Africa Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 75. Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 76. Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 77. UAE Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 78. UAE Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 79. UAE Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)2
Table 80. UAE Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 81. Saudi Arabia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)4
Table 82. Saudi Arabia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)4
Table 83. Saudi Arabia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 84. Saudi Arabia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)5
Table 85. South Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)7
Table 86. South Africa Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)7
Table 87. South Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)8
Table 88. South Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 89. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)0
Table 90. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)0
Table 91. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 92. Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)1
Table 93. South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)4
Table 94. South & Central America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)4
Table 95. South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 96. South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)5
Table 97. Brazil Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)7
Table 98. Brazil Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)7
Table 99. Brazil Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)8
Table 100. Brazil Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)8
Table 101. Argentina Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)0
Table 102. Argentina Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)0
Table 103. Argentina Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 104. Argentina Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)1
Table 105. Rest of South & Central America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)3
Table 106. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)3
Table 107. Rest of South & Central America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)4
Table 108. Rest of South & Central America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 109. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market6
Table 110. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market7
Table 111. Glossary of Terms7
LIST OF FIGURES
Figure 1. Blood Plasma Derivatives Market Segmentation
Figure 2. Blood Plasma Derivatives Market, by region
Figure 3. Global Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Blood Plasma Derivatives Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Blood Plasma Derivatives Market, by Geography (US$ Million)
Figure 7. Global Blood Plasma Derivatives Market – Leading Country Markets (US$ Million)
Figure 8. Global Blood Plasma Derivatives Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Blood Plasma Derivatives Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Blood Plasma Derivatives Market, by Geography – Forecast and Analysis (2020–2028)
Figure 18. Market Positioning of Key Players in Blood Plasma Derivatives Market
Figure 19. Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 20. Albumin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Factor VIII: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Factor IX: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Immunoglobulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. IgG: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. IgM: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. IgA: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. IgD: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. IgE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Hyperimmune Globulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Global Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 32. Hemophilia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Hypogammaglobulinemia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Immunodeficiency Diseases: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Von Willebrand Disease: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Applications: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 38. Hospitals: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Clinics: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Other End Users: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. North America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 42. North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 51. Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 52. United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 53. Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
Figure 54. Asia Pacific: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)5
Figure 55. Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 56. Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 57. Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
Figure 58. India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 59. Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
Figure 60. South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 61. Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 62. Middle East & Africa: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)7
Figure 63. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
Figure 64. Middle East & Africa: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)0
Figure 65. UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 66. Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 67. South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
Figure 68. Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 69. South & Central America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)3
Figure 70. South & Central America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 71. South & Central America: Blood Plasma Derivatives Market, by country, 2021 & 2028 (%)6
Figure 72. Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
Figure 73. Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 74. Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 75. Impact of COVID-19 Pandemic on North America Countries6
Figure 76. Impact of COVID-19 Pandemic on European Countries8
Figure 77. Impact of COVID-19 Pandemic in Asia Pacific Country Markets0
Figure 78. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets2
Figure 79. Impact of COVID-19 Pandemic on South and Central America Country Markets4
Figure 80. Growth Strategies in the Blood Plasma Derivatives Market5
The List of Companies - Blood Plasma Derivatives Market
- Grifols SA
- SK Plasma Co Ltd
- Octapharma AG
- Monobind Inc
- Intas Pharmaceuticals Ltd
- Fusion Health Care Pvt Ltd
- Takeda Pharmaceutical Co Ltd
- CSL Behring LLC
- LFB SA
- Kedrion SpA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For